Golde TE - Search Results

1

Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila.

De Mena L, Smith MA, Martin J, Dunton KL, Ceballos-Diaz C, Jansen-West KR, Cruz PE, Dillon KD, Rincon-Limas DE, Golde TE, Moore BD, Levites Y. De Mena L, et al. Among authors: golde te. Alzheimers Res Ther. 2020 Oct 17;12(1):132. doi: 10.1186/s13195-020-00698-z. Alzheimers Res Ther. 2020. PMID: 33069251 Free PMC article.

2

Homing in on intracellular Abeta?

Golde TE, Janus C. Golde TE, et al. Neuron. 2005 Mar 3;45(5):639-42. doi: 10.1016/j.neuron.2005.02.013. Neuron. 2005. PMID: 15748837 Free article. Review.

3

The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease.

Golde TE. Golde TE. Brain Pathol. 2005 Jan;15(1):84-7. doi: 10.1111/j.1750-3639.2005.tb00104.x. Brain Pathol. 2005. PMID: 15779241 Free PMC article. Review.

4

Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.

Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Levites Y, et al. Among authors: golde te. J Clin Invest. 2006 Jan;116(1):193-201. doi: 10.1172/JCI25410. Epub 2005 Dec 8. J Clin Invest. 2006. PMID: 16341263 Free PMC article.

5

Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.

Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE. Das P, et al. Among authors: golde te. J Neuroinflammation. 2006 Jul 26;3:17. doi: 10.1186/1742-2094-3-17. J Neuroinflammation. 2006. PMID: 16872492 Free PMC article.

6

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.

Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE. Levites Y, et al. Among authors: golde te. FASEB J. 2006 Dec;20(14):2576-8. doi: 10.1096/fj.06-6463fje. Epub 2006 Oct 26. FASEB J. 2006. PMID: 17068112

7

Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.

Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE. Levites Y, et al. Among authors: golde te. J Neurosci. 2006 Nov 15;26(46):11923-8. doi: 10.1523/JNEUROSCI.2795-06.2006. J Neurosci. 2006. PMID: 17108166 Free PMC article.

8

Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.

Golde TE, Dickson D, Hutton M. Golde TE, et al. Curr Alzheimer Res. 2006 Dec;3(5):421-30. doi: 10.2174/156720506779025189. Curr Alzheimer Res. 2006. PMID: 17168641 Review.

9

Abeta40 inhibits amyloid deposition in vivo.

Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E. Kim J, et al. J Neurosci. 2007 Jan 17;27(3):627-33. doi: 10.1523/JNEUROSCI.4849-06.2007. J Neurosci. 2007. PMID: 17234594 Free PMC article.

10

BRI2 (ITM2b) inhibits Abeta deposition in vivo.

Kim J, Miller VM, Levites Y, West KJ, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price RW, Smithson L, Sonoda L, Wagg K, Rangachari V, Zou F, Younkin SG, Graff-Radford N, Dickson D, Rosenberry T, Golde TE. Kim J, et al. Among authors: golde te. J Neurosci. 2008 Jun 4;28(23):6030-6. doi: 10.1523/JNEUROSCI.0891-08.2008. J Neurosci. 2008. PMID: 18524908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters